about
Hyperprolactinaemia - a problem in patients from the reproductive period to the menopause.Urinary retention in female OAB after intravesical Botox injection: who is really at risk?Both the middle and distal sections of the urethra may be regarded as optimal targets for 'outside-in' transobturator tape placementExpression of genes encoding extracellular matrix proteins: a macroarray study.Anatomical variation of bony pelvis from the viewpoint of transobturator sling placement for stress urinary incontinence.An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation.Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance.Dexketoprofen/tramadol 25 mg/75 mg: randomised double-blind trial in moderate-to-severe acute pain after abdominal hysterectomy.A classification of complications in urogynecology.The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial.Comparing raloxifene with continuous combined estrogen-progestin therapy in postmenopausal women: Review of Euralox 1.Primary non-Hodgkin's lymphoma of the uterine cervix mimicking leiomyoma: case report and review of the literature.Effectiveness of botulinum toxin injection in the treatment of de novo OAB symptoms following midurethral sling surgery.The polymorphisms of the MMP-1 and the MMP-3 genes and the risk of pelvic organ prolapse.Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms.Role of p53 pathway alterations in uterine carcinosarcomas (malignant mixed Müllerian tumors).Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial.Assessment of Th17 lymphocytes and cytokine IL‑17A in epithelial ovarian tumors.A new model of detrusor overactivity in conscious rats induced by retinyl acetate instillation.Biological markers with potential clinical value in endometrial cancer - review of the literature.Hysterectomy trends for benign indications over a 15-year period in an academic teaching center in Poland: a retrospective cohort study.Nonabsorbable urethral bulking agent - clinical effectiveness and late complications rates in the treatment of recurrent stress urinary incontinence after 2 years of follow-up.Impact of intravesical onabotulinumtoxinA on sexual function in women with OAB.Can botox improve night-time overactive bladder symptoms in women?Multiple recurrences of early-stage, endometrioid-type G2 endometrial cancer with a long-time follow-up: A case study.The Putative Role of TP53 Alterations and p53 Expression in Borderline Ovarian Tumors - Correlation with Clinicopathological Features and Prognosis: A Mini-Review.Ultra low dose continuous combined hormone replacement therapy with 0.5mg 17beta-oestradiol and 2.5mg dydrogesterone: protection of the endometrium and amenorrhoea rate.Self-perceived quality of life after pelvic organ prolapse reconstructive mesh surgery: prospective study.TGFβ-pathway is down-regulated in a uterine carcinosarcoma: a case study.Collagen deposition around polypropylene tapes implanted in the rectus fascia of female rats.Relationship between estrogen receptor-alpha polymorphism and serum levels of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, C-reactive protein and homocysteine in postmenopausal women.Correction to: Dexketoprofen/tramadol 25 mg/75 mg: randomised double-blind trial in moderate-to-severe acute pain after abdominal hysterectomy.Fas-Related Apoptosis of Peritoneal Fluid Macrophages in Endometriosis Patients: Understanding the Disease.Development and validation of the Polish version of the Urogenital Distress Inventory short form and the Incontinence Impact Questionnaire short form.Novel biomarkers of overactive bladder syndrome.Use of free uroflowmetry vs pressure-flow studies in the diagnosis of overactive bladder syndrome in females.An animal model of detrusor overactivity induced by depression.Reply from authors to the Letter to the Editor on RE: Futyma et al. use of uroflow parameters in diagnosing an overactive bladder-Back to the drawing board and ICS News 613.PROSPECT multicenter trial-a real milestone in prolapse surgery?Diagnostic and therapeutic recommendations for patients with nocturia.
P50
Q33704842-2798EF03-6CB3-486C-8407-E57550884A37Q33705306-3642E11C-A66D-4D9B-9D15-924290FE03F3Q34538480-B8707FFE-5709-4A4D-A230-32755FF8AB2CQ34556688-364D804F-27AE-4BBF-B688-1A86CDB37680Q35093710-0110E94F-DC4D-424A-8A29-C30A2E732625Q35707960-6F0B2E16-4676-422A-9B72-243103D991BCQ35886225-95AFACBD-62C7-43EA-ACD7-32F728A12870Q35902215-AB6C1D80-D29B-48BF-B865-2027D28EFEB0Q35903560-5810862C-C282-45B5-B2B2-471902760A60Q36086072-E71C1CC8-98E2-4E17-BB0E-FADE66181938Q36168926-197D5C05-D01A-4EE0-AE63-A94EA3A4D493Q36336156-542B94B3-5D56-4B1A-A9AA-28E86C3AD76DQ36615109-C7D8C717-3445-4755-98EE-27CA6235905EQ36898007-146D850B-91A8-4F83-93D9-E433F6EB1CEAQ37342324-52F44365-A194-40A9-A67E-146FC2EAD29AQ38230658-50CFBC5B-D765-4981-957D-5E86EB791510Q38460729-E81BD73A-EA5C-4525-B620-E40BEA0BB5CBQ38708318-320B9142-0742-4DA2-86CA-68AD3D95611FQ39009276-9925BA4B-F630-456E-A4D2-C74D70D11BA6Q39447431-CE0BFA85-1039-4951-8023-EDA040F0018BQ39600383-2A27F21A-8CA6-4B4C-B05D-9B671F472796Q40483925-55D6786B-BB01-483A-99D2-B5F3424B4B88Q40554763-7651796F-514C-469F-81EF-E2FFEE230F2DQ40887604-213C1587-5680-44BE-BFD9-F0722D85B2EAQ41379084-99749E69-4DB7-46C2-A522-512E9053B74CQ41721833-8DDF2F05-AD83-4449-8239-490E480FB6A1Q43105820-41FB9751-68DA-4CFE-B5B1-850CD592695DQ44371061-33B9B082-980D-4F8D-AD96-FC7D7A702C1FQ45917324-112DEE25-3C13-42EA-B339-F6BCD71D540DQ46606587-F0675391-1B71-4FDE-AE00-5C1671324BBAQ46984672-83DD4D57-948D-4EA6-9C61-7076B315E032Q47099873-2BC66B50-F5F2-48D1-9CA7-907232B0098DQ47109584-45FA7CF6-3E90-41FB-B61C-C418EDF1DAE6Q47341010-BFEA0470-D5A4-4B8D-A961-E8F4A72FF2A8Q47344230-5ADBC7D5-AB9D-44F5-BE74-FB3A54B4CBE4Q47945665-9E7BDFEE-4D06-4A68-BB00-7E04E6CBA459Q48058988-D39B0B27-1F32-4738-BB61-3C181FE2EBD7Q48197840-FA6BF0E7-54ED-4C9A-BE6B-A513485CA6AAQ48362251-8542B442-48AC-4F89-9831-F2D27440CB33Q48504091-8E2ABAEC-FA71-4FD9-955E-E4E45CD218F0
P50
description
researcher ORCID ID = 0000-0003-4138-332X
@en
wetenschapper
@nl
name
Tomasz Rechberger
@ast
Tomasz Rechberger
@en
Tomasz Rechberger
@es
Tomasz Rechberger
@nl
type
label
Tomasz Rechberger
@ast
Tomasz Rechberger
@en
Tomasz Rechberger
@es
Tomasz Rechberger
@nl
prefLabel
Tomasz Rechberger
@ast
Tomasz Rechberger
@en
Tomasz Rechberger
@es
Tomasz Rechberger
@nl
P1153
7006080439
P31
P496
0000-0003-4138-332X